Chart calendar Summit Therapeutics Inc.

574f43.Rfp6lEPxltiUaqsYBD2wYTmnvrkBn-d-kz7OVFLDvOA.IMI_3QTcxY78Puh9VFzpBkne-Nd1yIRMvgaiBSKA7KIdt06mBcnkj_oM3A~c91aebd13ce839ba3ceca55b4c14be5a

Upcoming events on Summit Therapeutics Inc.

04/11/2026

Présentation aux Actionnaires / Analystes

20:00
04/11/2026

Extraordinary General Meeting

Past events on Summit Therapeutics Inc.

24/07/2026

Earnings presentation

00:30
24/07/2026

Earnings release - Q2 2026

10/06/2026

Annual General Meeting

16:30
10/06/2026

Présentation aux Actionnaires / Analystes

16:30
01/06/2026

Information meeting

15:00
24/02/2026

Earnings presentation

01:30
24/02/2026

Earnings release - Q4 2025

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million GBP
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
56,8
-

2,94


41,9


429

EBITDA
Million GBP
Released
Forecast
Spread
0,00


-108
-171
36.45%
-810
-366
-121.37%

-573


-551


-316

EBIT
Million GBP
Released
Forecast
Spread
0,00


-179
-175
-2.12%
-810
-714
-13.56%

-670


-723


-453

Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
0,00


-175
-177
1.11%
-800
-807
0.88%

-679


-725


-358

Net income
Million GBP
Released
Forecast
Spread
-486


-175
-177
1.11%
-800
-788
-1.43%

-697


-738


-432

EPS
GBP
Released
Forecast
Spread
-0,78


-0,25
-0,25
2.3%
-1,07
-0,95
-12.54%

-0,86


-0,87


-0,51

Announcement Date20/02/2424/02/2523/02/26-

Quarterly results

Fiscal PeriodJune 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million GBP
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
57,4
-
0,00
56,8
-
0,00
0,04
-
0,00
0,00
-

0,05


2,99


5,22


8,20


7,76


11,0

EBITDA
Million GBP
Released
Forecast
Spread
-34,5
-46,0
24.96%
-50,3
-55,6
9.51%

-52,7

-174
-47,7
-265.75%
-167
125
-233.18%
-144
-131
-9.53%
-166
-126
-31.77%

-145


-149


-203


-210







EBIT
Million GBP
Released
Forecast
Spread
-51,9
-48,5
-7.04%
-50,3
-54,7
8.11%
-424
-54,7
-674.26%
-175
-36,3
-381.59%
-167
-71,7
-132.5%
-144
-178
19.2%
-166
-156
-5.95%

-167


-200


-180


-185


-181


-206

Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
-48,4
-52,4
7.69%
-47,3
-52,6
10.02%
-422
-56,7
-644.02%
-173
-73,7
-134.91%
-162
-169
3.84%
-139
-186
25.16%
-162
-162
-0.07%

-169


-220


-169


-174


-179


-185

Net income
Million GBP
Released
Forecast
Spread
-48,4
-52,4
7.69%
-47,3
-52,6
10.02%
-422
-55,3
-662.69%
-173
-77,2
-124.25%
-162
-150
-7.9%
-139
-172
18.86%
-162
-157
-3.05%

-175


-219


-169


-174


-179


-205

EPS
GBP
Released
Forecast
Spread
-0,06
-0,07
12.11%
-0,07
-0,07
2.97%
-0,57
-0,07
-657.74%
-0,23
-0,15
-53.06%
-0,21
-0,10
-106.71%
-0,18
-0,21
15.3%
-0,21
-0,22
3.58%

-0,21


-0,27


-0,20


-0,21


-0,21


-0,22

Announcement Date24/02/2501/05/2511/08/2520/10/2523/02/2630/04/2623/07/26------
Today

Earnings presentation

16:00
Today

Earnings release - Q3 2026

Today

Earnings release - Q3 2026

Today

Earnings release - Q3 2026

Today

Earnings release - Q3 2026

Today

Earnings presentation

01:00
30/10/2026

Earnings release - Q3 2026

30/10/2026

Extraordinary General Meeting

12:00
31/10/2026

Earnings release - Q3 2026

31/10/2026

Earnings release - Q3 2026

Past sector events for Summit Therapeutics Inc.

Today

Board of Directors Meeting

29/10/2026

Earnings release - Q3 2026

29/10/2026

Earnings presentation

00:30
Today

Earnings release - Q3 2026

Today

Earnings release - Q3 2026

28/10/2026

Information meeting

20:00
28/10/2026

Earnings release - Q3 2026

28/10/2026

Board of Directors Meeting

28/10/2026

Earnings release - Q3 2026

28/10/2026

Earnings release - Q3 2026

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Summit Therapeutics Inc.

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - Summit Therapeutics Inc.

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Summit Therapeutics Inc.
  1. Stock Market
  2. Stocks
  3. SMMT Stock
  4. Calendar Summit Therapeutics Inc.